Vycor Medical, Inc.
VYCO
$0.0679
-$0.0001-0.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.80% | -498.00% | 67.32% | 67.13% | -79.38% |
| Total Depreciation and Amortization | 7.64% | 0.00% | 0.64% | 3.31% | -0.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 291.49% | -- | -100.00% | 231.82% | -21.43% |
| Change in Net Operating Assets | -233.87% | -37.86% | 745.26% | -88.30% | 327.37% |
| Cash from Operations | -464.76% | -87.79% | 4,426.32% | -65.45% | 136.91% |
| Capital Expenditure | 104.55% | -- | -- | -- | -68.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 104.00% | -- | -100.00% | 111.86% | -47.50% |
| Total Debt Issued | -100.00% | -- | -- | -- | -102.69% |
| Total Debt Repaid | 50.53% | -165.09% | 33.75% | -64.95% | 66.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -142.25% | 410.38% | 33.75% | -40.35% | -133.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -235.77% | -49.20% | 662.69% | -13.56% | -175.16% |